Study sparks optimism for ovarian-cancer test developed at MGH

It took nearly two decades, but a little known research project at Massachusetts General Hospital is shaping up as a potentially powerful weapon in the fight against ovarian cancer.
The results from a 15-year study conducted by the University College London appear to be the most-promising signs yet that a locally developed technology can catch the disease at its earliest stages using a blood test. In the study, 20 percent fewer women who were screened using the test died from ovarian cancer compared to women who weren’t screened at all.